目的观察辨证施治联用欣梅乐治疗骨质疏松性骨折的疗效和安全性。方法 60例患者分为二组,观察组30例(辨证施治联用欣梅乐治疗),对照组30例(单用欣梅乐治疗),二组治疗3个疗程,每个疗程15d。比较二组疗效,同时观察记录不良反应。结果观察组镇痛优良率为80%,骨折愈合优良率为80%,骨折疏松症优良率86.7%,疗效明显高于对照组。结论辨证施治联用欣梅乐治疗骨质疏松性骨折疗效稳定,不良反应少,值得进一步研究探讨。 Objective To observe the efficacy and safety of syndrome differentiation combined with Xinmeile in the treatment of osteoporotic fracture. Methods Sixty patients were divided into two groups. The observation group consisted of 30 patients (treated by syndrome differentiation combined with Xinmeile) and 30 patients (treated with Xinmeile alone). The two groups were treated for 3 cycles of 15 days each. The efficacy of the two groups were compared, and the adverse reactions were observed and recorded. Results The excellent and good rate of analgesia in the observation group was 80%, the excellent rate of fracture healing was 80% and the rate of excellent and good rate of fracture and osteoporosis was 86.7%. The curative effect was obviously higher than that of the control group. Conclusion Syndrome Differentiation combined with Xin Mei Lok treatment of osteoporotic fractures with stable efficacy, fewer adverse reactions, it is worth further study.